Meet Dr. Steve Rose
Steve is highly respected for his expertise and tireless commitment to finding treatments and cures for vision-robbing retinal diseases.
Posts Tagged ‘Stem Cells’
It’s a mystery that has confounded scientists for many years: Why don’t mice with Usher syndrome type 1 — one of three types of combined blindness and deafness in humans — lose vision? It is an important question, because mouse models help us understand how vision is lost and how effective treatments might be. But if the mouse isn’t losing vision, how can we tell if a potential vision-saving therapy is working?
Read more
After a rigorous review process, the Foundation is funding eight new research projects for a wide range of conditions, including Leber congenital amaurosis (LCA), age-related macular degeneration (AMD) and retinitis pigmentosa (RP). You can read about these exciting projects in an article recently posted on the Foundation’s homepage.
Israeli Research Group Receives $1.33 Million to Advance Stem Cell Treatment
I was heartened to just learn that researchers from the Hadassah-Hebrew Medical Center in Jerusalem are receiving a $1.33 million grant from the Israeli government to advance their development of a stem cell treatment for people with dry age-related macular degeneration (AMD Hadassah is also funded by the Foundation Fighting Blindness. We are providing the group with a three-year, $300,000 grant for development of stem cell therapies.
Have I Got a Cure for You! Debunking an Alleged Treatment on the Internet
It seems there is no dearth of fantastic cures being touted on the Internet and in email inboxes these days. Sort of reminds me of those old Western movies where the itinerant peddler sells the magic elixir that will cure any and all ailments you have. Read more
Japanese Group Plans Induced Pluripotent Stem Cell Clinical Trial
I just learned some promising news from the stem cell research front. RIKEN, an innovative research group in Japan, is hoping to launch a clinical trial of an age-related macular degeneration (AMD) treatment derived from induced pluripotent stem cells (iPSC). Based on my current knowledge, this would be the first-ever iPSC-based treatment for the retina to move into a human study.
Read more